On March 28th, 2018, AICM hosted IPAC General Meeting in Shanghai. Ms. Beryl MA , AICM Executive Director, briefed the antitrust code and chaired the morning session. AICM Board Director, Mr. Jan Kreibaum attended the meeting and made an opening speech. Mr. Jan mentioned that with high involvement of member participation (>90%) in IPAC activities led by IPAC's leadership, IPAC's core value were well acknowledged by the board and member companies. Extensive dialogues were channeled through the platform with policy makers in 2017. The priorities were settled upon budget approved and more subjects are covered further under IPAC in 2018 upon member's needs.
Ms. Karin XU, IPAC Chair, made committee's report to all participants. Upon board approval, IPAC adjusted structure upon review of member's needs, regulatory development and advocacy priorities in 2018. The previous sub-committees of toxicology, eco-toxicology and risk assessment and emission trade system were adjusted to ad hoc task forces. The life sciences applications sub-committee, led by Mr. Wells XIE (Lubrizol), were established with the extended scope of API, excipient and medical devices applications. Subsequently, sub-committee chairs of Regional Regulatory Exchange Platform, Hazardous Chemical Safety Management, Environmental Management of Chemical Substances, Site HSE, Food Safety, Automobile & Electrical and Electronics Application, Coating, Life Sciences summarized achievements in 2017 and reported work priorities in 2018. Finally, IPAC specially invited Mr. WANG, Wu from CNCIC to introduce AICM EHS Database system.
Concerning the China's Institutional Reshuffle Plan, IPAC will monitor the implementation upon subjects.
